SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Concord Biotech - Quaterly Results

08 Feb 2024 Evaluate
The company's total revenue for the quarter ended December 2023 saw a slight change in the total revenue, having registered a total revenue of Rs. 2407.96 millions.Net profit declined -5.72% to Rs. 745.54 millions from Rs. 790.76 millions.The Operating Profit of the company witnessed a decrease to 1141.17 millions from 1209.29 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202312 202212 % Var
Sales 2407.96 2406.83 0.05 2407.96 2406.83 0.05 2407.96 2406.83 0.05
Other Income 81.87 92.50 -11.49 81.87 92.50 -11.49 81.87 92.50 -11.49
PBIDT 1141.17 1209.29 -5.63 1141.17 1209.29 -5.63 1141.17 1209.29 -5.63
Interest 4.95 9.09 -45.54 4.95 9.09 -45.54 4.95 9.09 -45.54
PBDT 1136.22 1200.20 -5.33 1136.22 1200.20 -5.33 1136.22 1200.20 -5.33
Depreciation 135.37 137.70 -1.69 135.37 137.70 -1.69 135.37 137.70 -1.69
PBT 1000.85 1062.50 -5.80 1000.85 1062.50 -5.80 1000.85 1062.50 -5.80
TAX 255.31 271.74 -6.05 255.31 271.74 -6.05 255.31 271.74 -6.05
Deferred Tax -2.69 7.87 -134.18 -2.69 7.87 -134.18 -2.69 7.87 -134.18
PAT 745.54 790.76 -5.72 745.54 790.76 -5.72 745.54 790.76 -5.72
Equity 104.62 104.62 0.00 104.62 104.62 0.00 104.62 104.62 0.00
PBIDTM(%) 47.39 50.24 -5.68 47.39 50.24 -5.68 47.39 50.24 -5.68

Concord Biotech Share Price

1067.40 0.00 (0.00%)
21-Apr-2026 09:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.95
Dr. Reddys Lab 1242.75
Cipla 1230.00
Zydus Lifesciences 935.00
Lupin 2337.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×